Please see full Prescribing Information for AREXVY. About GSK GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by respiratory syncytial virus due to certain ...

GSK’s Arexvy has received expanded approval in Canada for preventing RSV-related lower respiratory tract disease in adults ...

Drugmaker GSK saw a sharp drop in revenue from its blockbuster Arexvy vaccine in the third ... currently planning launches for five major new product approval opportunities next year.” ...

Frankly, no. Nevertheless, many products include registration cards harvesting personal information that companies then sell to marketers. The companies get money; you get peppered with spam and ...

with weakening demand for the Covid-19 products, Pfizer has touted Abrysvo as one of the primary revenue driver. Abrysvo’s ...

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on October 9. Graham ...

The company has important products such as Shingrix and Arexvy in its vaccine segment. GSK also presents a strong portfolio of HIV and oncology therapeutics. I also believe that GSK has made some ...

mResvia’s prescribing information indicates ... with both GSK and Pfizer’s products. There’s still one more step before Moderna’s vaccine can take on Arexvy and Abrysvo in the market.

Such tools are used by IT operations managers, site reliability engineers, cloud and platform teams, application developers and software product owners. Everyday information workers and consumers ...

Emma Walmsley, CEO of GSK, is nearly eight years into her effort to return the British pharma company to growth, and her work ...

Pfizer gave little information ... this morning that Arexvy had helped the group deliver an “excellent performance” in 2023, adding that it is planning at least 12 major product launches ...